This site is intended only for healthcare professionals resident in the United Kingdom
Inflectra® is a biosimilar of infliximab, a monoclonal antibody, used in the treatment of Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and severe plaque psoriasis.
Inflectra® | Dosing
Prescribing Information
Inflectra® Summary of Product Characteristics | Legal Category: POM Basic NHS Price: 1 vial £377.66
Dosing in Ulcerative Colitis (UC)
Inflectra® dosing is based on patient's disease, weight and condition2.
PP-IFA-GBR-0451. December 2020
